Rodeo Therapeutics is a preclinical-stage biopharmaceutical company. It is focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.
Rodeo Therapeutics total Funding
Rodeo Therapeutics latest funding size
Time since last funding
|a year ago|
Rodeo Therapeutics investors
|WuXi AppTec, Accelerator Corporation, Johnson & Johnson Innovation, AbbVie Biotech Ventures, Watson Fund, ARCH Venture Partners, WRF Capital, Eli Lilly, Alexandria Venture Investments|